[jlengelbrecht]

No but the project has undergone an in depth evaluation from Open Collective prior to being accepted for fiscal hosting. Additionally I am in contact with an Attorney who is reviewing the projects stance. The project as it is right now is aims to not cross any boundaries that would make it a medical device. The platform does not control insulin or make dosing recommendations. It's still in early alpha but I have made my position clear. The platform serves as a tool to help you understand your data and help you have better discussions with your medical provider.